Literature DB >> 26493006

Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.

Megolhubino Terhuja1, Paramasivam Saravanan2, Ramasamy Periyasamy Tamilselvan1.   

Abstract

Foot-and-mouth disease (FMD) is one of the most contagious and economically important diseases of cloven-hoofed livestock. Currently used inactivated FMD vaccines have short lived immunity besides risk of handling live virus. We studied recombinant FMD virus like particles (VLPs) encoded by FMDV type O/IND/R2/75 polyprotein genes expressed in Sf9 cells and adjuvanted with CpG or Poly I:C in inducing protective immune response in guinea pigs. Guinea pigs immunized with VLP + CpG vaccine had shown markedly higher cell mediated immunity (CMI) in comparison to the conventional vaccine group as evident from higher levels of IgG2 than IgG1. Although the humoral response was less in VLP + CpG compared to conventional vaccine, the lymphocyte stimulation index was more in VLP + CpG compared to conventional and VLP + Poly I:C vaccine groups. Finally the challenge experiments on 28 and 56 dpv had shown 75% protection in VLP + CpG immunized guinea pigs primary and boosted animals, while 50% and 62% protection in VLP + Poly I:C in primary and boosted animals, respectively. In conclusion, CpG adjuvant was found to be superior followed by ISA206 and Poly I:C in eliciting protection in VLP based FMD vaccines in guinea pigs.
Copyright © 2015 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Baculovirus expression system; CMI response; Challenge studies; CpG; Poly I:C; Virus like particles (VLPs)

Mesh:

Substances:

Year:  2015        PMID: 26493006     DOI: 10.1016/j.biologicals.2015.09.004

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  10 in total

Review 1.  Adjuvant formulations for virus-like particle (VLP) based vaccines.

Authors:  Velasco Cimica; Jose M Galarza
Journal:  Clin Immunol       Date:  2017-08-03       Impact factor: 3.969

2.  Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus.

Authors:  Michael Puckette; Victoria Primavera; Erica Martel; Jose Barrera; William Hurtle; Benjamin Clark; Barbara Kamicker; Mariceny Zurita; David Brake; John Neilan
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

3.  Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection.

Authors:  Clarice L Perry; Brianne N Banasik; Summer R Gorder; Jingya Xia; Sarah Auclair; Nigel Bourne; Gregg N Milligan
Journal:  J Immunol Methods       Date:  2016-09-19       Impact factor: 2.303

4.  Enhanced Immune Responses with Serum Proteomic Analysis of Hu Sheep to Foot-and-Mouth Disease Vaccine Emulsified in a Vegetable Oil Adjuvant.

Authors:  Xuemei Cui; Yong Wang; Ran Guan; Meiqian Lu; Lijia Yuan; Wei Xu; Songhua Hu
Journal:  Vaccines (Basel)       Date:  2020-04-15

Review 5.  SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies.

Authors:  Lanxiang Huang; Yuan Rong; Qin Pan; Kezhen Yi; Xuan Tang; Qian Zhang; Wei Wang; Jianyuan Wu; Fubing Wang
Journal:  Asian J Pharm Sci       Date:  2020-09-01       Impact factor: 6.598

Review 6.  Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective.

Authors:  Raj Kumar Singh; Gaurav Kumar Sharma; Sonalika Mahajan; Kuldeep Dhama; Suresh H Basagoudanavar; Madhusudan Hosamani; B P Sreenivasa; Wanpen Chaicumpa; Vivek Kumar Gupta; Aniket Sanyal
Journal:  Vaccines (Basel)       Date:  2019-08-16

7.  zzm321990 Salmonella Vaccine Vector System for Foot-and-Mouth Disease Virus and Evaluation of Its Efficacy with Virus-Like Particles.

Authors:  Yong Zhi; Hyun Jung Ji; Huichen Guo; Jae Hyang Lim; Eui-Baek Byun; Woo Sik Kim; Ho Seong Seo
Journal:  Vaccines (Basel)       Date:  2021-01-05

8.  Using Self-Assembling ADDomer Platform to Display B and T Epitopes of Type O Foot-and-Mouth Disease Virus.

Authors:  Chaowei Luo; Quanhui Yan; Juncong Huang; Jiameng Liu; Yuwan Li; Keke Wu; Bingke Li; Mingqiu Zhao; Shuangqi Fan; Hongxing Ding; Jinding Chen
Journal:  Viruses       Date:  2022-08-18       Impact factor: 5.818

9.  Development of Drugs Based on High-Polymeric Double-Stranded RNA for Antiviral and Antitumor Therapy.

Authors:  E D Danilenko; A O Belkina; G M Sysoeva
Journal:  Biochem Mosc Suppl B Biomed Chem       Date:  2019-12-04

10.  Promotion of Cellular and Humoral Immunity against Foot-and-Mouth Disease Virus by Immunization with Virus-Like Particles Encapsulated in Monophosphoryl Lipid A and Liposomes.

Authors:  Woo Sik Kim; Yong Zhi; Huichen Guo; Eui-Baek Byun; Jae Hyang Lim; Ho Seong Seo
Journal:  Vaccines (Basel)       Date:  2020-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.